Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore-Reference-Cited by-同舟云学术

Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore

Published:2022-06-06 Issue:8 Volume:75 Page:1442-1445
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Premikha M¹^ORCID,Chiew Calvin J¹,Wei Wycliffe E¹,Leo Yee Sin²³⁴⁵⁶,Ong Benjamin¹⁴,Lye David Chien²³⁴⁵,Lee Vernon J¹⁶,Tan Kelvin Bryan¹⁶

Affiliation:

1. Ministry of Health , Singapore

2. National Centre for Infectious Diseases , Singapore

3. Lee Kong Chian School of Medicine, Nanyang Technological University , Singapore

4. Yong Loo Lin School of Medicine, National University of Singapore , Singapore

5. Department of Infectious Diseases, Tan Tock Seng Hospital , Singapore

6. Saw Swee Hock School of Public Health, National University of Singapore , Singapore

Abstract

Abstract Compared with individuals vaccinated with Pfizer-BioNTech/Comirnaty, recipients of Sinovac-CoronaVac and Sinopharm were 2.37 (95% CI, 2.29–2.46) and 1.62 (95% CI, 1.43–1.85) times more likely to be infected with coronavirus disease 19, respectively, while individuals vaccinated with Moderna were 0.42 (95% CI, 0.25–0.70) times less likely to develop severe disease.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac288/43959261/ciac288.pdf

Reference15 articles.

1. Considerations in boosting COVID-19 vaccine immune responses;Krause;Lancet,2021

2. Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions—United States, March–August 2021;Self;MMWR Morb Mortal Wkly Rep,2021

3. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis;Rotshild;Sci Rep,2021

4. A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease;Higdon;medRxiv,25, 2021

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness and safety of BNT162b2 and CoronaVac in Hong Kong: A target trial emulation;International Journal of Infectious Diseases;2024-09

2. A real-world study of BBIBP-CorV vaccine effectiveness in a Sri Lanka rural province;Heliyon;2024-09

3. Efficacy of additional hemoperfusion in hospitalized patients with severe to critical COVID-19 disease;Scientific Reports;2024-07-31

4. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19;Annual Review of Immunology;2024-06-28

5. The Predictors of COVID-19 Immunogenicity Elicited by Vaccines Against SARS-CoV-2 in Stem Cell Transplant Recipients;Flora the Journal of Infectious Diseases and Clinical Microbiology;2024-06-25